ABSENCE OF PREFERENTIAL UPTAKE OF [I-125]IODODIHYDRORHODAMINE 123 BY 4 HUMAN-TUMOR XENOGRAFTS

被引：0
|
作者：
KINSEY, BM [1 ]
VANDENABBEELE, AD [1 ]
ADELSTEIN, SJ [1 ]
KASSIS, AI [1 ]
机构：
[1] HARVARD UNIV,SCH MED,DEPT RADIOL NUCL MED,SHIELDS WARREN RADIAT LAB,50 BINNEY ST,BOSTON,MA 02115
来源：
CANCER RESEARCH | 1989年 / 49卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5986 / 5988
页数：3
相关论文
共 50 条
  • [41] COMPARISON OF (IUDR)-I-125 AND THYMIDINE-H-3 UPTAKE IN CARCINOMA AND BENIGN HYPERPLASIA OF HUMAN-PROSTATE IN ORGAN-CULTURE
    MISTRY, DH
    RICHES, AC
    WEAVER, JPA
    JOURNAL OF PATHOLOGY, 1983, 139 (04): : 477 - 477
  • [42] UPTAKE OF I-125 LABELED MONOCLONAL-ANTIBODY FOR PREDICTION OF ANTICANCER DRUG ACTIVITY AGAINST HUMAN-TUMORS IN NUDE-MICE
    LOCKSHIN, A
    KOZIELSKI, T
    ROBERTSON, JA
    VAUGHN, KW
    YATES, RC
    STEHLIN, JS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 414 - 414
  • [43] CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB
    CARAGLIA, M
    TAGLIAFERRI, P
    CORREALE, P
    GENUA, G
    PINTO, A
    DELVECCHIO, S
    ESPOSITO, G
    BIANCO, AR
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (03) : 150 - 156
  • [44] HIGH-AFFINITY BINDING OF I-125-LABELED HUMAN-TUMOR NECROSIS FACTOR (LUKII) TO SPECIFIC CELL-SURFACE RECEPTORS
    RUBIN, BY
    ANDERSON, SL
    SULLIVAN, SA
    WILLIAMSON, BD
    CARSWELL, EA
    OLD, LJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (03): : 1099 - 1104
  • [45] [I-125]-SB-207710 LABELS SMALL 5-HT4 RECEPTOR POPULATIONS IN PORCINE AND HUMAN ATRIUM
    KAUMANN, AJ
    LYNHAM, J
    BROWN, AM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P39 - P39
  • [46] PHARMACOKINETICS OF TUMOR-LOCALIZATION AND ORGAN DISTRIBUTION OF I-125 LABELED HUMAN MONOCLONAL-ANTIBODIES IN HUMAN-COLON TUMOR XENOGRAFT-BEARING NUDE-MICE
    MCCABE, RP
    PETERS, LC
    HASPEL, MV
    POMATO, N
    HANNA, MG
    NUCLEAR MEDICINE AND BIOLOGY, 1986, 13 (06): : 658 - 658
  • [47] BIODISTRIBUTION AND TUMOR-LOCALIZATION OF I-125 LABELED HUMAN-IGM MONOCLONAL-ANTIBODY COU-1 IN NUDE-MICE BEARING HUMAN TUMOR GRAFTS
    DITZEL, H
    RASMUSSEN, JW
    ERB, K
    BORUPCHRISTENSEN, P
    JENSENIUS, JC
    ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1991, 4 (04): : 507 - 515
  • [48] INTERSTITIAL RADIATION-THERAPY WITH I-125 SEEDS IN UNRESECTABLE LOCAL TUMOR RECURRENCE IN DIFFERENTIATED AND NON-DIFFERENTIATED THYROID CARCINOMAS WITHOUT UPTAKE OF RADIOIODINE
    KANITZ, W
    KOPP, J
    HAMPERL, WD
    HEIDENREICH, P
    WAGNER, T
    WIENER KLINISCHE WOCHENSCHRIFT, 1990, 102 (09) : 277 - 280
  • [49] IN-VITRO UPTAKE OF I-125 IODOBENZOATE C-MYB VARIANT OLIGODEOXYNUCLEOTIDES PHOSPHOROTHIOATES IN HUMAN INTESTINAL SMOOTH-MUSCLE CELLS (HISM)
    ZAKNUN, J
    ELMALEH, DR
    BABICH, JW
    RAPAPORT, E
    METELEV, V
    ZAMECNIK, PC
    FISCHMAN, AJ
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P151 - P152
  • [50] Preferential Tumor Targeting and Selective Tumor Cell Cytotoxicity of 5-[131/125I]lodo-4′-Thio-2′-Deoxyuridine
    Morgenroth, Agnieszka
    Deisenhofer, Sandra
    Glatting, Gerhard
    Kunkel, Falk H-G.
    Dinger, Cornelia
    Zlatopolskiy, Boris
    Vogg, Andreas T. J.
    Kull, Thomas
    Reske, Sven N.
    CLINICAL CANCER RESEARCH, 2008, 14 (22) : 7311 - 7319
12345